AIDX 8-K 2026-09-02

20/20 Biolabs, Inc. (AIDX) 8-K dated 2026-09-02 — accession 0001213900-26-096743. This URL is the filing, not the AIDX hub.

20/20 Biolabs, Inc. (AIDX) common stock.

20/20 Biolabs, Inc. filed a 8-K on 2026-09-02. Accession 0001213900-26-096743.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AIDX revenue for 2025-12-31 was $2.0M. Net income was -$3.7M. Revenue was up 16.7% from 2024-12-31 to 2025-12-31.

Not investment advice. The AIDX SEC hub lists recent forms. The stock page is the research view.